Enovis | ENOV - Selling And Administration Expenses

Stock Price
24.09
Daily Change
-2.03 -7.77%
Monthly
-4.40%
Yearly
-33.19%
Q2 Forecast
25.97

Enovis reported $282.81M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Alcidion AUD 1.09M 184K Dec/2025
Ambu A/S DKK 684M 5M Mar/2026
Apollo Hospitals Enterprise Ltd INR 7.25B 382M Mar/2025
Coloplast 2.64B 52M Dec/2025
Convatec Group USD 420.3M 210.35M Dec/2024
Diasorin EUR 56M 49.25M Mar/2026
Enovis USD 282.81M 12.37M Mar/2026
Gulf Medical Proj AED 915K 52K Dec/2025
Hoya 15.96B 471M Mar/2026
Med Life RON 23.07M 3.23M Sep/2025
Oriola-kd EUR 13M 3.1M Sep/2025
Rede D'or Sao Luiz BRL 145.65M 76.19M Mar/2026
Siemens Healthineers EUR 963M 38M Mar/2026
Sonova Holding CHF 880.2M 300K Jun/2025